Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 576

1.

Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.

Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen MK.

J Pediatr. 2019 Mar 13. pii: S0022-3476(19)30127-1. doi: 10.1016/j.jpeds.2019.01.039. [Epub ahead of print]

PMID:
30878206
2.

[Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges].

Herta T, Beuers U.

Radiologe. 2019 Mar 15. doi: 10.1007/s00117-019-0513-x. [Epub ahead of print] Review. German.

PMID:
30874827
3.

Treatment of primary sclerosing cholangitis in children.

Laborda TJ, Jensen MK, Kavan M, Deneau M.

World J Hepatol. 2019 Jan 27;11(1):19-36. doi: 10.4254/wjh.v11.i1.19. Review.

4.

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.

Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV.

Hepatology. 2019 Jan 19. doi: 10.1002/hep.30509. [Epub ahead of print]

PMID:
30661255
5.

Inhibitory Effect of Ursodeoxycholic Acid on Clostridium difficile Germination Is Insufficient to Prevent Colitis: A Study in Hamsters and Humans.

Palmieri LJ, Rainteau D, Sokol H, Beaugerie L, Dior M, Coffin B, Humbert L, Eguether T, Bado A, Hoys S, Janoir C, Duboc H.

Front Microbiol. 2018 Nov 22;9:2849. doi: 10.3389/fmicb.2018.02849. eCollection 2018.

6.

Statin Use is Associated with Improved Outcomes of Patients With Primary Sclerosing Cholangitis.

Stokkeland K, Höijer J, Bottai M, Söderberg-Löfdal K, Bergquist A.

Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31245-X. doi: 10.1016/j.cgh.2018.11.002. [Epub ahead of print]

PMID:
30448601
7.

Autoimmune Liver Diseases in Children.

Mataya L, Patel N, Azzam RK.

Pediatr Ann. 2018 Nov 1;47(11):e452-e457. doi: 10.3928/19382359-20181022-02. Review.

PMID:
30423188
8.

Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.

Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T.

Hepatol Commun. 2018 Sep 25;2(11):1369-1378. doi: 10.1002/hep4.1251. eCollection 2018 Nov.

9.

Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.

Chen HL, Wu SH, Hsu SH, Liou BY, Chen HL, Chang MH.

J Biomed Sci. 2018 Oct 26;25(1):75. doi: 10.1186/s12929-018-0475-8. Review.

10.

Autoimmune sclerosing cholangitis: Evidence and open questions.

Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani G.

J Autoimmun. 2018 Dec;95:15-25. doi: 10.1016/j.jaut.2018.10.008. Epub 2018 Oct 23. Review.

PMID:
30366655
11.

Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients.

Šarenac TM, Mikov M.

Front Pharmacol. 2018 Sep 25;9:939. doi: 10.3389/fphar.2018.00939. eCollection 2018. Review.

12.

Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.

Kerkar N, Chan A.

Clin Liver Dis. 2018 Nov;22(4):689-702. doi: 10.1016/j.cld.2018.06.005. Review.

PMID:
30266157
13.

Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.

Leoni MC, Amelung L, Lieveld FI, van den Brink J, de Bruijne J, Arends JE, van Erpecum CP, van Erpecum KJ.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):37-44. doi: 10.1016/j.clinre.2018.08.006. Epub 2018 Sep 13.

PMID:
30219692
14.

Cholestatic liver diseases: new targets, new therapies.

Santiago P, Scheinberg AR, Levy C.

Therap Adv Gastroenterol. 2018 Aug 24;11:1756284818787400. doi: 10.1177/1756284818787400. eCollection 2018. Review.

15.

Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2-/- mice and human primary sclerosing cholangitis.

Meng F, Kennedy L, Hargrove L, Demieville J, Jones H, Madeka T, Karstens A, Chappell K, Alpini G, Sybenga A, Invernizzi P, Bernuzzi F, DeMorrow S, Francis H.

Lab Invest. 2018 Nov;98(11):1465-1477. doi: 10.1038/s41374-018-0101-0. Epub 2018 Aug 24.

16.

Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.

Lemoinne S, Pares A, Reig A, Ben Belkacem K, Kemgang Fankem AD, Gaouar F, Poupon R, Housset C, Corpechot C, Chazouillères O.

Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):521-528. doi: 10.1016/j.clinre.2018.06.009. Epub 2018 Aug 9.

PMID:
30100231
17.

Post-Transplant Disease Recurrence in Pediatric PSC.

Soufi N, Bazerbachi F, Deneau M.

Curr Gastroenterol Rep. 2018 Aug 6;20(9):44. doi: 10.1007/s11894-018-0649-2. Review.

PMID:
30083892
18.

Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis.

Al Qatarneh S, Michel HK, Lindblad D, Ozolek J, Venkat V, Weiner DJ.

J Pediatr. 2018 Dec;203:457-457.e1. doi: 10.1016/j.jpeds.2018.05.054. Epub 2018 Jul 2. No abstract available.

PMID:
30041939
19.

Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.

Sedki M, Levy C.

Curr Gastroenterol Rep. 2018 Jun 9;20(7):29. doi: 10.1007/s11894-018-0635-8. Review.

PMID:
29886518
20.

Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment.

Pataia V, Papacleovoulou G, Nikolova V, Samuelsson AM, Chambers S, Jansen E, Taylor PD, Poston L, Williamson C.

Int J Obes (Lond). 2019 Feb;43(2):319-330. doi: 10.1038/s41366-018-0095-0. Epub 2018 May 24.

Supplemental Content

Loading ...
Support Center